Shortly afterward, a compound directly related to FAP-2286 called 3BP-3940 was studied in clinical settings and also displayed excellent properties as a molecular PET imaging agent, including a remarkably high tumor-to-background ratio and minimal renal accumulation (21, 22). This evidence concerns the gene FAP and neoplasm.